Chemical discoveries rarely follow a direct path. Benzyl alcohol derivatives trace back to foundational organic synthesis methods in the early-to-mid 20th century, when researchers like Woodward and Robinson made catecholamines a core area in biochemistry. This compound, with its dihydroxybenzyl skeleton and aminomethyl side group, reflects how synthetic chemistry borrows from nature, echoing dopamine’s structure. The tartrate salt form solves real-world problems—improving solubility for delivery or formulation. Scientists looking to stabilize active pharmaceutical ingredients have leaned into tartrate and other organic acids, building on time-tested salt formation strategies from the earlier days of drug development.
Speaking plainly, the molecule carries a benzyl alcohol backbone fitted with an aminomethyl group in the alpha position, flanked by two hydroxy groups at 3 and 4. The L-tartrate salt allows the product to serve in diverse roles, mostly in pharmacology and chemical research. Historically, such compounds have gained attention for their roles as intermediates in active drugs, especially where amine functionalities and catechol scaffolds interact with biological targets. The end-product usually appears as a crystalline powder, sometimes off-white, reflecting the typical nature of organic salts formed with tartrate.
This salt stands out thanks to its moderate hydrophilicity and ability to dissolve in polar solvents. The melting point sits well below 200°C, making it manageable in most lab and industrial environments. The tartrate counterion enhances water solubility versus the free base. The compound smells faintly sweet—a nod to its benzyl origins—and shows a predictable reactivity profile due to the phenolic hydroxy groups. Its chemical stability rests on well-handled moisture and light exposure; improper storage can introduce slow hydrolysis or oxidation, leading to color changes or loss of potency. Knowing these properties isn’t academic; my time handling catecholic compounds taught me the cost of ignoring their tendency to darken after a few days at room temperature.
Assay reports for these salts regularly cite purity above 98%, with careful monitoring for residual solvents. Moisture content, dictated by Karl Fischer analysis, generally must stay below 1%. Quality assurance measures step up compliance with international standards such as ICH Q7 for active pharmaceutical ingredients. Every commercial batch gets a unique lot code, manufacturer’s name, and expiry date printed directly on the label, along with the molecular formula and, in most regulated environments, a QR code linking to the batch’s certificate of analysis. This traceability isn’t a formality; it underpins product recalls or investigations when unexpected adverse effects appear.
Most synthetic chemists start with protected catecholamines, using stepwise methylation, amination, and then deprotection strategies to assemble the backbone. Once the parent base has been synthesized and purified—often using chromatographic techniques suited for small-scale or preparative HPLC—the salt forms in situ by titrating with a stoichiometric amount of L-tartaric acid dissolved in ethanol or water. Precipitation often happens rapidly, and the resultant salt crystallizes out, allowing for filtration and subsequent drying under vacuum. Having worked through similar syntheses, I’ve seen how minor tweaks—solvent choice, temperature, concentration—can sharply influence yield, crystal habit, and purity.
The compound’s phenolic hydroxy groups lend themselves to straightforward methylation or acylation, opening routes for further derivative synthesis. The aminomethyl function, with its basicity and nucleophilicity, attaches well to various carboxylic acids or isocyanates, essential for drug discovery or ligand design. Oxidation remains the biggest threat to catecholic systems; atmospheric oxygen will convert the catechol to o-quinone, so every bench chemist learns the value of exclusion techniques—nitrogen atmosphere, antioxidants, or storing under inert gas. These practical tweaks keep the compound stable enough to act as a building block or screening agent in med-chem campaigns.
The naming game with complex organics confuses even seasoned scientists. This compound turns up as “(-)-Dopamine Tartrate” in pharma supply catalogs, though systematic IUPAC nomenclature lengthens the label considerably. Some catalogs offer it under more traditional terms, like “L-3,4-dihydroxy-alpha-aminomethylbenzyl alcohol tartrate.” Researchers wanting analytical standards often see reference to CAS numbers, but in many working labs, shorthand terms catch on—what matters is getting the ordered material into the hands that need it. This lack of naming consensus sometimes leads to double-ordering or confusion between similar analogs.
People handling these salts need solid training. The aminomethyl group can act as a mild irritant, especially after skin contact or inhalation, so gloves and particulate mask remain staples. Safety guidelines—built on estimation and lab data—set occupational exposure limits, but experience teaches not to cut corners unless you enjoy calling occupational health. MSDS documentation emphasizes the need for chemical fume hoods, especially during weighing or mixing, since minor inhalation can cause headaches or mild central stimulation—no surprise given the catechol backbone’s biological relevance. Proper waste disposal and spill procedures, such as dilution with large amounts of water and absorption with inert materials, reinforce the culture of safety in chemical labs.
Derivatives like these serve as backbone intermediates in synthesizing dopamine analogs or as calibration standards in analytical chemistry. I’ve encountered them mainly in neurobiology research, investigating receptor agonists and antagonists for diseases like Parkinson’s. Beyond biomedical science, the salt also appears in some specialty materials research, serving as a monomer or modifier where interaction with transition metals is desired. Pharmaceutical companies have turned to such salts in prodrug development, targeting better solubility and controlled release profiles in oral formulations.
Ongoing R&D focuses on the salt’s pharmacokinetics profile, especially in modifying the basic structure to optimize BBB penetration or receptor selectivity. Contract research organizations, driven by the pressure to discover and patent novel neurologically active compounds, often start with this salt’s versatile structure. New formulation approaches aim to unlock depot-release or transdermal applications, linking the compound’s hydrophilicity with advanced delivery systems like cyclodextrin complexes or nanocarriers. The real-world advantage of these approaches hinges on getting reproducible, reliable results for both in-vitro screening and animal studies, where careful handling and formulating can shave months off research timelines.
Toxicological studies—mostly in rodent models—show low acute toxicity at doses likely to be handled in a lab. Chronic administration in animal studies sometimes produces mild hepatic enzyme elevation or behavioral changes, likely stemming from interaction with dopamine pathways. I remember high school chemistry labs where “Don’t taste or touch” summed up the safety talk on catecholics; real-world toxicology digs much deeper, with modern studies employing in vitro cytotoxicity assays and automated behavioral scoring to quantify subtle effects. The data, though, suggest that with good industrial hygiene, routine lab exposure stays well below the risk threshold. Regulatory agencies like the European Chemicals Agency and U.S. EPA still require periodic review of all animal and human data, and companies frequently update SDS sheets to stay current with best practices.
Growth in precision medicine and analytical chemistry will keep salts like this relevant. Drug developers see the functionalization power of the aminomethyl group on catecholic frameworks as a launching point for more selective ligands or novel therapeutics. Analytical chemists with demands for reference standards with high traceability lean on such materials for routine HPLC or GC calibration. As artificial intelligence speeds up structure-activity relationship mining, expect to see more nuanced derivatives, tuned for better metabolic stability or target affinity, entering pre-clinical pipelines. My prediction: demand for high-purity, well-characterized salts like this won’t slow down as long as neurobiology and bespoke drug targeting remain frontiers in biomedical research.
Standing in a lab, holding a vial of benzyl alcohol derivative salt, you realize this isn’t everyday table salt. It lands in a unique spot in pharmaceutical research and production. Most often, scientists see it as a stabilizer and a stepping stone for creating important medications. Its profile as a salt offers special benefit: it helps transform active ingredients into forms the body can use more easily, making a real difference in accessibility and effectiveness.
Researchers with a few years of hands-on work behind them know this compound for its chiral properties. That “(-)-” in the name signals the molecule twists light in a certain way, giving it the power to boost how drugs interact with the body. Many modern drugs rely on this kind of specificity. If you have ever benefited from a medicine that hits its target with minimal side effects, chances are good some careful chiral chemistry backed that safety and reliability.
New drug candidates get their first real look in laboratories stocked with compounds like this. Think of it as a set of building blocks for biochemists creating neurologically active agents or cardiovascular drugs. By using this salt form, they increase their odds of getting an active compound that stays stable during storage or shipping. Nobody wants a medicine that falls apart before it can be used—patients and doctors alike rely on those molecular safeguards.
Beyond drug design, this salt plays a part in formulation studies. Creating an injectable solution that doesn’t irritate the tissue or lose potency often comes down to details at the molecular level. Benzyl alcohol derivatives pop up as solvents or auxiliary agents in these formulas. The tartrate part contributes to solubility and sometimes acts to buffer pH, keeping everything in a range that is both safe and effective.
Having worked with regulated substances, I recognize the role documentation and oversight play. Regulatory agencies like the FDA expect thorough data for each step, from the synthetic route to handling and labeling. Benzyl alcohol derivatives sometimes raise safety questions in relation to allergic reactions or dose limits in injectable products. Toxicologists and quality managers use this information to guide decisions, always erring on the side of caution to protect patients.
In response to demand for safer, more effective drugs, the pharmaceutical industry faces pressure to find routes that cut waste without sacrificing quality. Labs focus on “greener” chemistry and better purification techniques. As new regulations emerge—especially those tied to quality by design principles—compounds like benzyl alcohol alpha-(aminomethyl)-3,4-dihydroxy-, tartrate stay relevant because they are time-tested, well-documented, and trusted in both manufacturing and research.
Thinking about the years spent in R&D, I see first-hand how little things add up. A salt that improves stability or a chemical tweak that enhances solubility becomes a key deciding factor for success. For now, these molecules remain points of progress. The pharmaceutical world leans on them, and the people at the end of the line—patients with complex health needs—benefit most.
It’s a practical partnership between chemistry and medicine, with every small choice in the lab affecting health outcomes around the world.
Most new compounds hit the market with technical sheets full of safety claims, certifications, and regulatory details. Anyone who has spent time reading food, supplement, or chemical labels knows what this looks like: numbers, fine print, scientific jargon. These details matter—regulations should exist for good reason—but many stories about compounds fail to connect numbers to real-world health. Risk doesn’t stop just because an agency gives its stamp of approval.
Friends and colleagues often ask: will this supplement, sweetener, or pharmaceutical compound truly help or harm me? Having worked in nutrition clinics and talked to dozens of doctors and chemists, I see where the science and the lived experience sometimes clash. Take aspartame—approved since the 1980s—yet its name sparks anxiety. Some point out that regulatory bodies like FDA and EFSA have declared it safe for consumption up to a certain dose, but public confusion hasn’t gone away. The same story repeats for newer substances, whether they end up in plant-based meat, cosmetics, or even COVID-19 treatments.
Every country has its own patchwork of regulations. Europe bans some colorants found in U.S. cereals. Japan restricts certain preservatives that appear in global soft drinks. One agency’s 'safe' can clash with another’s ban. These gaps aren’t just technical squabbles—they can confuse doctors and consumers alike. Reliable evidence doesn’t always mean consensus, since regulators sometimes move slowly or rely on company-supplied studies.
Animal studies help flag dangers. Rats may show liver problems at high doses of a new additive or pharmaceutical. Still, humans and rats process chemicals differently, and what makes one species sick doesn’t always translate. Real safety emerges over years, sometimes decades, once enough people have used the substance and patterns of harm or benefit appear.
Research means more than counting laboratory endpoints. People need to see honest discussions about studies: Who paid for them? How many participants? Were negative results hidden? I’ve seen peer-reviewed journals retract articles when undisclosed funding or manipulated data comes to light—a sobering reminder. Transparency matters, because informed consumers and healthcare providers need access to all sides of the story, not just what marketing campaigns highlight.
Doctors recommend asking tough questions. What long-term studies exist? Any reports of harm, even rare ones? For parents, the stakes feel even higher. Open-access science makes a difference: people deserve the chance to see safety evaluations, not just reassurance or marketing. Regulatory bodies should update guidelines as new data emerges—old safety assessments grow stale as new findings come in.
Reading labels makes a difference. People can start slow, watch for reactions, and keep a written record when they try something new. Trusted scientists, not celebrities or anonymous blogs, make the best guides. Every new compound brings a promise—better health, longer shelf life, convenience—but the best choices balance that promise against what independent research says now, not just what’s on a glossy label or trending in social media feeds.
Health experts, researchers, and regulators carry a real responsibility: put people first, not profits or convenience. Consumers who look past bold claims and seek solid evidence play a direct role in raising safety standards for everyone. This mindset, built on skepticism and curiosity, keeps families safer and pushes the world closer to honest science and real well-being.
Product storage goes far beyond stacking boxes in a warehouse. Difficulties start with temperature swings, humidity, and the day-to-day exposure to dust or sunlight most people overlook. Nobody wants to open a shipment only to find the contents spoiled, clumped together, or, worse, hazardous. To keep things running, clear attention to each environmental factor makes a difference.
High temperatures break down chemicals, make food items lose potency, or cause liquids to separate and degrade. Cold can make some products brittle, or encourage condensation inside containers. Keeping a steady range means using reliable climate controls—refrigerated storage or insulated containers if the outside temperature threatens the integrity of the goods. Even a few hours out of range can ruin an entire shipment. In my own experience, I’ve seen shipments of perishable materials arrive unusable just because they sat on the loading dock too long. That single oversight wiped out thousands in value.
Certain products—cosmetics, pharmaceuticals, and foodstuffs—change simply from being exposed to sunlight or open air. Light breaks down sensitive ingredients, and oxygen sparks unwanted reactions. Containers tell stories: fading labels, warped lids, pitted surfaces. Proper storage calls for tight seals, opaque containers, and prompt resealing after each use. Forgetting even one of these steps starts a slow decline at a cellular level, threatening user health or leading to off flavors and smells.
Damp storage sets the stage for mold, rust, or caking, especially with powders and grains. Absorbent materials like silica packets buy extra protection, but they don’t replace dry, well-ventilated rooms. Stack pallets off the ground, keep aisles open, and check for leaks on a regular basis. I remember one warehouse that ignored roof leaks. After the rainy season, half their backstock had to get tossed—months of work lost to a poor roof, not just poor judgment.
Handling rules aren’t just legalese dreamed up by risk managers. Chemical products may require gloves, goggles, or designated storage away from heat sources. Food surfaces should stay clean to keep out bacteria and prevent cross-contamination. Clear signage and basic employee training offer more real-world value than another row of expensive shelving. I’ve seen toxic cleaners accidentally stored with packaging for edible goods—one droplet would’ve spelled disaster for a family.
Keep a regular schedule for inspections. Check for bulging containers, odd smells, changes in color, or broken safety seals. Automated tracking tools hardly substitute for a curious human’s look and nose. Problems caught early cost less to fix and, more importantly, keep end users safe.
Storage and handling boil down to respect—for the material, the people using it, and the end user. Every step saved in the name of speed or cost adds risk. A little vigilance and honest communication prove far more valuable than any shortcut.
A lot of chemicals end up around us—sometimes in our homes, sometimes on the job. Take this compound. It gets used in products for cleaning, manufacturing, and sometimes even food processing. Over time, researchers have learned a fair bit about what it can do, both useful and risky.
Plenty of people have felt irritation after coming into contact with it, especially on skin or in the eyes. Redness, stinging, and itching aren’t rare at all, and I’ve actually had a patch of skin flare up for hours from a careless splash. The burning sensation doesn’t calm down right away, especially without quick washing. Breathing dust or fumes makes things worse—coughing, trouble catching your breath, or even a scratchy throat can follow. For people with asthma or allergies, inhaling it ramps up the risk.
Scientists have focused a lot on possible chronic health problems. Some animal studies turned up changes in organs from months of low-level exposure, raising red flags about lasting effects in humans. The International Agency for Research on Cancer (IARC) and similar organizations often step in to check for cancer connections. A few studies point toward possible links, depending on dose and genetic makeup, but certainty still needs more data. Even lacking hard proof, I prefer to play it safe and stick to small amounts and protective gear.
Not everyone reacts the same. Kids, pregnant women, or people with some chronic conditions get hit harder. Lower body weight and changing metabolism make the side effects stronger. Some cases in the news described children landing in the ER after accidental spills at home. This tells us that safe storage and close supervision matter as much as clear labeling.
Few people realize how easily this compound flows through water or soil. Wholesale dumps and improper disposal end up contaminating groundwater. Studies show elevated concentrations downstream from factories, affecting fish and insects. Frogs, which live at the edge of water and land, show high sensitivity, leading to missing species in polluted streams. I’ve seen firsthand how even small spills at local riversides lead to warnings and temporary bans for fishers and swimmers.
At workplaces, proper training makes the biggest difference. Gloves, goggles, and solid ventilation cost less than hospital bills. Proper signage with clear warnings cuts down on accidents. At home, always read the fine print—never pour leftovers down drains or toss in regular trash. Cities set up hazard waste days for a reason, and the turnout shows people understand the stakes.
Doctors and toxicologists keep up the pressure for clearer studies. Regulatory agencies review new data every few years. Until everyone agrees on total safety, it pays to stay informed. Stick to recommended doses. Store it out of reach. And never underestimate the impact on water, air, and food supply. Real safety isn’t just someone else’s job—it belongs to each of us.
Turning to a complex name like benzyl alcohol, alpha-(aminomethyl)-3,4-dihydroxy-, (-)-, tartrate (1:1) (salt) usually means dealing with compounds at the heart of pharmaceutical discovery or advanced research. Its chemical make-up deserves some close attention. This salt forms by combining two quite distinct parts: a specific derivative of benzyl alcohol carrying both amine and catechol groups, and tartaric acid as the counterion.
The molecular formula for the benzyl alcohol derivative itself goes as follows: C8H11NO2 (for the aminomethyl-3,4-dihydroxybenzyl alcohol portion). The (-)-tartrate, derived from tartaric acid, brings in C4H6O6. In the 1:1 salt form, the combined formula reads: C8H11NO2 · C4H6O6. It’s a mouthful, but every atom counts here.
Structurally, the benzyl alcohol backbone anchors a group at the alpha (first carbon after the benzene ring) position, holding an aminomethyl and two hydroxyls on the aromatic ring. That arrangement gives this molecule the ability to form strong interactions — both hydrogen bonding thanks to those hydroxyl groups, and ionic or polar connections because of the amine and acid groups in the salt.
Once you look past the names and formulas, the value in real-world terms starts to show. Complex salts like this usually find their way into specialized medicine or biological research. By combining the active benzyl alcohol derivative with (-)-tartrate, scientists can improve water solubility, tune bioavailability, or control how the molecule behaves in the body.
There’s also a story in the stereochemistry. The “(-)-” tells you this molecule isn’t symmetrical. That’s not just a technical detail — this mirrors what living systems care about. Enzymes in the body recognize shape. Give them the wrong twist, and a molecule might do nothing, or worse, cause harm. Matching the stereochemistry matters for effectiveness and safety, a lesson reinforced time and again in pharmaceutical development.
Handling laboratory chemicals like this one never boils down to only the chemistry. With potential for both therapeutic effects and off-target risks, strict protocols follow every step from storage to disposal. Laboratories lean on decades of experience and published guidelines to keep both researchers and the broader community out of harm’s way. Professionals rely on evidence — studies of stability, reactivity, and toxicity — to set practices.
Green chemistry aims to minimize environmental impact. Waste management for these compounds ties into a bigger system, making sure hazardous byproducts don’t seep into the water or soil. Safety data isn’t just a formality; it’s a lifeline for those who work with these salts.
Curiosity about how such salts behave stretches far. Whether the goal is to design new medicines, understand brain chemistry, or model complex biological pathways, these structures do real work. The hope is this knowledge translates into solutions for real-world health crises, faster diagnoses, or even breakthroughs in green chemistry. Reliable, fact-based communication keeps these ambitions both grounded and moving forward.
Providing high-quality chemical products and logistics solutions for global trade partners.
